XM
IONS icon

XTX Markets’s Ionis Pharmaceuticals IONS Stock Holding History

XTX Markets’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$294K Sell
5,206
-1,745
-25% -$87K 0.61% 52
2020
Q3 		$330K Buy
6,951
+3,135
+82% +$174K 1.59% 12
2020
Q2 		$225K Buy
+3,816
New +$212K 0.76% 68

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

XTX Markets's IONS Position: Q4 2020 in Review

XTX Markets reduced its Ionis Pharmaceuticals (IONS) stake by 25% in Q4 2020, selling an estimated $87K and leaving 5,206 shares worth $294K. The position accounts for 0.61% of the portfolio, ranked #52.

XTX Markets first reported a position in IONS in Q2 2020 and has held it in 3 quarters since. The position peaked at $330K in Q3 2020. 383 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

  • XTX Markets held 5,206 shares of Ionis Pharmaceuticals worth $294K as of Q4 2020.
  • XTX Markets sold 1,745 Ionis Pharmaceuticals shares in Q4 2020, an estimated $87K.
  • Ionis Pharmaceuticals made up 0.61% of XTX Markets's portfolio in Q4 2020, its #52 holding.
  • XTX Markets first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
  • XTX Markets's Ionis Pharmaceuticals position peaked at $330K in Q3 2020.
  • 383 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.